By identifying key mitochondrial genes (e.g., ATP5MC3, GLYCTK, NT5DC2) and immune traits (e.g., HLA‐DR + DCs) associated with DKD risk, this study highlights potential therapeutic targets for early intervention. This evidence concerns the gene NT5DC2 and diabetic kidney disease.